Top

Surgical Endoscopy

Published in:

01-09-2009

The use of medication after laparoscopic antireflux surgery

Authors: Ruxandra Ciovica, Otto Riedl, Christoph Neumayer, Wolfgang Lechner, Gerhard P. Schwab, Michael Gadenstätter

Published in: Surgical Endoscopy | Issue 9/2009

Abstract

Background

Laparoscopic antireflux surgery (LARS) significantly improves symptoms of gastro-esophageal reflux disease (GERD) and quality of life. Nevertheless, 14–62% of patients report using antisecretory medication after surgery, although only a tiny percentage has proven recurrence of GERD. We sought to determine symptoms of GERD, quality of life, and use of medication before and after LARS, and to compare our findings with those from previous studies.

Methods

Five hundred fifty-three patients with GERD who underwent LARS were evaluated before and at 1 year after surgery. After surgery, multidisciplinary follow-up care was provided for all patients by surgeons, psychologists, dieticians, and speech therapists.

Results

Symptoms of GERD and quality of life improved significantly and only 4.2% of patients still required medication after surgery [proton pump inhibitors (PPI) (98.4 vs. 2.2%; p < 0.01), prokinetics (9.6 vs. 1.1%; p < 0.01), and psychiatric medication (8 vs. 1.6%; p < 0.01)].

Conclusion

LARS significantly reduced medication use at 1-year follow-up. However, these effects might be attributed, in part, to the multidisciplinary follow-up care. Further studies are therefore required to investigate which patients may benefit from multidisciplinary follow-up care and whether its selective application may reduce the need for medication after LARS.

DeVault KR, Castell DO (2005) Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 100:190–200PubMedCrossRef

Fass R (2007) Erosive esophagitis and nonerosive reflux disease (nerd): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol 41:131–137PubMedCrossRef

Provenzale D (2000) Epidemiology of gastroesophageal reflux disease. In: Orlando RC (ed) Gastroesophageal reflux disease. Dekker, New York, pp 85–99

El-Serag HB (2007) Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 5(1):17–26PubMedCrossRef

Ciovica R, Gadenstatter M, Klingler A, Neumayer C, Schwab GP (2005) Laparoscopic antireflux surgery provides excellent results and quality of life in gastroesophageal reflux disease patients with respiratory symptoms. J Gastrointest Surg 9:633–637PubMedCrossRef

Gadenstatter M, Wykypiel H, Schwab GP, Profanter C, Wetscher GJ (1999) Respiratory symptoms and dysphagia in patients with gastroesophageal reflux disease: a comparison of medical and surgical therapy. Langenbecks Arch Surg 384:563–567PubMedCrossRef

Lindstrom DR, Wallace J, Loehrl TA, Merati AL, Toohill RJ (2002) Nissen fundoplication surgery for extraesophageal manifestations of gastroesophageal reflux (eer). Laryngoscope 112:1762–1765PubMedCrossRef

Novitsky YW, Zawacki JK, Irwin RS, French CT, Hussey VM, Callery MP (2002) Chronic cough due to gastroesophageal reflux disease: efficacy of antireflux surgery. Surg Endosc 16:567–571PubMedCrossRef

Kauer WK, Stein HJ, Mobius C, Siewert JR (2004) Assessment of respiratory symptoms with dual ph monitoring in patients with gastro-oesophageal reflux disease. Br J Surg 91:867–871PubMedCrossRef

10.

Eckardt VF (1988) Does healing of esophagitis improve esophageal motor function? Dig Dis Sci 33:161–165PubMedCrossRef

11.

Kaul BK, DeMeester TR, Oka M, Ball CS, Stein HJ, Kim CB, Cheng SC (1990) The cause of dysphagia in uncomplicated sliding hiatal hernia and its relief by hiatal herniorrhaphy. A roentgenographic, manometric, and clinical study. Ann Surg 211:406–410PubMedCrossRef

12.

Osler W (1892) The principles and practice of medicine. Appleton, New York

13.

Kamolz T, Velanovich V (2002) Psychological and emotional aspects of gastroesophageal reflux disease. Dis Esophagus 15:199–203PubMedCrossRef

14.

Johnston BT, Lewis SA, Love AH (1995) Psychological factors in gastro-oesophageal reflux disease. Gut 36:481–482PubMedCrossRef

15.

Diaz de Liano A, Yarnoz C, Artieda C, Flores L, Garde C, Romeo I, Ortiz H (2006) Gastroesophageal reflux: prevalence of psychopathological disorders and quality of life implications. Dis Esophagus 19:373–376PubMedCrossRef

16.

Johnston B, Lewis S, Love A (1992) Do heartburn sufferers have specific personality profile? Gastroenterology 102:A91

17.

Velanovich V (2003) The effect of chronic pain syndromes and psychoemotional disorders on symptomatic and quality-of-life outcomes of antireflux surgery. J Gastrointest Surg 7:53–58PubMedCrossRef

18.

Maunder RG (1998) Panic disorder associated with gastrointestinal disease: review and hypotheses. J Psychosom Res 44:91–105PubMedCrossRef

19.

Bradley LA, Richter JE, Pulliam TJ, Haile JM, Scarinci IC, Schan CA, Dalton CB, Salley AN (1993) The relationship between stress and symptoms of gastroesophageal reflux: the influence of psychological factors. Am J Gastroenterol 88:11–19PubMed

20.

Velanovich V, Karmy-Jones R (1998) Measuring gastroesophageal reflux disease: relationship between the health-related quality of life score and physiologic parameters. Am Surg 64:649–653PubMed

21.

Revicki DA, Wood M, Maton PN, Sorensen S (1998) The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 104:252–258PubMedCrossRef

22.

Wetscher GJ, Glaser K, Gadenstaetter M, Profanter C, Hinder RA (1999) The effect of medical therapy and antireflux surgery on dysphagia in patients with gastroesophageal reflux disease without esophageal stricture. Am J Surg 177:189–192PubMedCrossRef

23.

Wetscher GJ, Hinder RA, Perdikis G, Wieschemeier T, Stalzer R (1996) Three-dimensional imaging of the lower esophageal sphincter in healthy subjects and gastroesophageal reflux. Dig Dis Sci 41:2377–2382PubMedCrossRef

24.

Gadenstatter M, Klingler A, Prommegger R, Hinder RA, Wetscher GJ (1999) Laparoscopic partial posterior fundoplication provides excellent intermediate results in gerd patients with impaired esophageal peristalsis. Surgery 126:548–552PubMedCrossRef

25.

Lundell LR (1994) The knife or the pill in the long-term treatment of gastroesophageal reflux disease? Yale J Biol Med 67:233–246PubMed

26.

Jenkinson AD, Kadirkamanathan SS, Scott SM, Yazaki E, Evans DF (2004) Relationship between symptom response and oesophageal acid exposure after medical and surgical treatment for gastro-oesophageal reflux disease. Br J Surg 91:1460–1465PubMedCrossRef

27.

Frazzoni M, Manno M, De Micheli E, Savarino V (2006) Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations? Dig Liver Dis 38:643–648PubMedCrossRef

28.

Oberg S, Ritter MP, Crookes PF, Fein M, Mason RJ, Gadenstatter M, Brenner CG, Peters JH, DeMeester TR (1998) Gastroesophageal reflux disease and mucosal injury with emphasis on short-segment Barrett’s esophagus and duodenogastroesophageal reflux. J Gastrointest Surg 2:547–553PubMedCrossRef

29.

Lagergren J, Bergstrom R, Lindgren A, Nyren O (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825–831PubMedCrossRef

30.

Saco LS, Orlando RC, Levinson SL, Bozymski EM, Jones JD, Frakes JT (1982) Double-blind controlled trial of bethanechol and antacid versus placebo and antacid in the treatment of erosive esophagitis. Gastroenterology 82:1369–1373PubMed

31.

Graham DY, Patterson DJ (1983) Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis. Dig Dis Sci 28:559–563PubMedCrossRef

32.

Kamolz T, Granderath FA, Pointner R (2003) The outcome of laparoscopic antireflux surgery in relation to patients’ subjective degree of compliance with former antireflux medication. Surg Laparosc Endosc Percutan Tech 13:155–160PubMedCrossRef

33.

Bixquert-Jimenez M, Bixquert-Pla L (2005) Antidepressant therapy in functional gastrointestinal disorders. Gastroenterol Hepatol 28:485–492PubMedCrossRef

34.

Rykova SM, Pogromov AP, Diukova GM, Vein AM (2003) Psychophysiologic disorders in patients with functional disorders of upper sections of the gastrointestinal tract and with gastroesophageal reflux disease. Eksp Klin Gastroenterol 4:21–26, 113

35.

Singh S, Bailey RT, Stein HJ, DeMeester TR, Richter JE (1992) Effect of alprazolam (xanax) on esophageal motility and acid reflux. Am J Gastroenterol 87:483–488PubMed

36.

Rubin J, Brock-Utne JG, Dimopoulos GE, Downing JW, Moshal MG (1982) Flunitrazepam increases and diazepam decreases the lower oesophageal sphincter tone when administered intravenously. Anaesth Intensive Care 10:130–132PubMed

37.

Botoman VA (2002) Noncardiac chest pain. J Clin Gastroenterol 34:6–14PubMedCrossRef

38.

Sontag SJ (2002) Persistent gastroesophageal reflux disease symptoms on standard proton-pump inhibitor therapy. Gastroenterol Clin North Am 31:77–84CrossRef

39.

Schmulson MJ, Valdovinos MA (2004) Current and future treatment of chest pain of presumed esophageal origin. Gastroenterol Clin North Am 33:93–105PubMedCrossRef

40.

DeMeester TR, Bonavina L, Albertucci M (1986) Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg 204:9–20PubMedCrossRef

41.

Hinder RA, Filipi CJ, Wetscher G, Neary P, DeMeester TR, Perdikis G (1994) Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg 220:472–481PubMedCrossRef

42.

Schwizer W, Hinder RA, DeMeester TR (1989) Does delayed gastric emptying contribute to gastroesophageal reflux disease? Am J Surg 157:74–81PubMedCrossRef

43.

Hinder RA, Stein HJ, Bremner CG, DeMeester TR (1989) Relationship of a satisfactory outcome to normalization of delayed gastric emptying after Nissen fundoplication. Ann Surg 210:458–464PubMedCrossRef

44.

Scheffer RC, Samsom M, Frakking TG, Smout AJ, Gooszen HG (2004) Long-term effect of fundoplication on motility of the oesophagus and oesophagogastric junction. Br J Surg 91:1466–1472PubMedCrossRef

45.

Farrell TM, Richardson WS, Trus TL, Smith CD, Hunter JG (2001) Response of atypical symptoms of gastro-oesophageal reflux to antireflux surgery. Br J Surg 88:1649–1652PubMedCrossRef

46.

Watson DI, Chan AS, Myers JC, Jamieson GG (1997) Illness behavior influences the outcome of laparoscopic antireflux surgery. J Am Coll Surg 184:44–48PubMed

47.

Velanovich V, Karmy-Jones R (2001) Psychiatric disorders affect outcomes of antireflux operations for gastroesophageal reflux disease. Surg Endosc 15:171–175PubMedCrossRef

48.

Kamolz T, Bammer T, Granderath FA, Pointner R (2001) Laparoscopic antireflux surgery in gastro-oesophageal reflux disease patients with concomitant anxiety disorders. Dig Liver Dis 33:659–664PubMedCrossRef

49.

Lord RV, Kaminski A, Oberg S, Bowrey DJ, Hagen JA, DeMeester SR, Sillin LF, Peters JH, Crookes PF, DeMeester TR (2002) Absence of gastroesophageal reflux disease in a majority of patients taking acid suppression medications after Nissen fundoplication. J Gastrointest Surg 6:3–9PubMedCrossRef

50.

Anthone GJ, Lord RV, DeMeester TR, Crookes PF (2003) The duodenal switch operation for the treatment of morbid obesity. Ann Surg 238:618–627PubMed

51.

Liu JY, Woloshin S, Laycock WS, Schwartz LM (2002) Late outcomes after laparoscopic surgery for gastroesophageal reflux. Arch Surg 137:397–401PubMedCrossRef

52.

Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufman JP, Sampliner R, Schnell T, Sontag S, Vlahcevic ZR, Young R, Williford W (2001) Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 285:2331–2338PubMedCrossRef

53.

Ollyo JB, Fontolliet C, Lang BF (1992) La nouvelle classification de Savary des oesophagites de reflux. Acta Endosc 22:307–320CrossRef

54.

Riddell RH (1996) The biopsy diagnosis of gastroesophageal reflux disease, “Carditis”, and barrett’s esophagus, and sequelae of therapy. Am J Surg Pathol 20(Suppl 1):S31–S50PubMed

55.

Zaninotto G, DeMeester TR, Schwizer W, Johansson KE, Cheng SC (1988) The lower esophageal sphincter in health and disease. Am J Surg 155:104–111PubMedCrossRef

56.

DeMeester TR, Wang CI, Wernly JA, Pellegrini CA, Little AG, Klementschitsch P, Bermudez G, Johnson LF, Skinner DB (1980) Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg 79:656–670PubMed

57.

American Psychiatric Association (2007) Diagnostic and statistical manual of mental disorders. DSM-IV-TR^TM (4th edn)

58.

Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmulling C, Neugebauer E, Troidl H (1995) Gastrointestinal quality of life index: development, validation and application of a new instrument. Br J Surg 82:216–222PubMedCrossRef

59.

Eypasch E, Wood-Dauphinee S, Williams JI, Ure B, Neugebauer E, Troidl H (1993) The gastrointestinal quality of life index. A clinical index for measuring patient status in gastroenterologic surgery. Chirurg 64:264–274PubMed

60.

Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA (1996) Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 183:217–224PubMed

61.

Ciovica R, Gadenstatter M, Klingler A, Lechner W, Riedl O, Schwab GP (2006) Quality of life in gerd patients: medical treatment versus antireflux surgery. J Gastrointest Surg 10:934–939PubMedCrossRef

62.

Murphy LR (1996) Stress management in work settings: a critical review of the health effects. Am J Health Promot 11:112–135PubMed

63.

Lund RJ, Wetcher GJ, Raiser F, Glaser K, Perdikis G, Gadenstatter M, Katada N, Filipi CJ, Hinder RA (1997) Laparoscopic toupet fundoplication for gastroesophageal reflux disease with poor esophageal body motility. J Gastrointest Surg 1:301–308PubMedCrossRef

64.

Wetscher GJ, Glaser K, Wieschemeyer T, Gadenstaetter M, Prommegger R, Profanter C (1997) Tailored antireflux surgery for gastroesophageal reflux disease: effectiveness and risk of postoperative dysphagia. World J Surg 21:605–610PubMedCrossRef

65.

Wetscher GJ, Glaser K, Gadenstatter M, Wieschemeyer T, Profanter C, Klinger P (1998) Laparoscopic partial posterior fundoplication improves poor oesophageal contractility in patients with gastrooesophageal reflux disease. Eur J Surg 164:679–684PubMedCrossRef

66.

Chrysos E, Tsiaoussis J, Zoras OJ, Athanasakis E, Mantides A, Katsamouris A, Xynos E (2003) Laparoscopic surgery for gastroesophageal reflux disease patients with impaired esophageal peristalsis: total or partial fundoplication? J Am Coll Surg 197:8–15PubMedCrossRef

67.

Bammer T, Hinder RA, Klaus A, Klingler PJ (2001) Five- to eight-year outcome of the first laparoscopic Nissen fundoplications. J Gastrointest Surg 5:42–48PubMedCrossRef

68.

Desai KM, Frisella MM, Soper NJ (2003) Clinical outcomes after laparoscopic antireflux surgery in patients with and without preoperative endoscopic esophagitis. J Gastrointest Surg 7:44–51PubMedCrossRef

69.

Dallemagne B, Weerts J, Markiewicz S, Dewandre JM, Wahlen C, Monami B, Jehaes C (2006) Clinical results of laparoscopic fundoplication at ten years after surgery. Surg Endosc 20:159–165PubMedCrossRef

70.

Anvari M, Allen C (2003) Five-year comprehensive outcomes evaluation in 181 patients after laparoscopic Nissen fundoplication. J Am Coll Surg 196:51–57PubMedCrossRef

71.

Peters JH, DeMeester TR, Crookes P, Oberg S, de Vos Shoop M, Hagen JA, Bremner CG (1998) The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with “typical” symptoms. Ann Surg 228:40–50PubMedCrossRef

72.

Campos GM, Peters JH, DeMeester TR, Oberg S, Crookes PF, Tan S, DeMeester SR, Hagen JA, Bremner CG (1999) Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 3:292–300PubMedCrossRef

73.

DeMeester TR, Stein HJ (1992) Minimizing the side effects of antireflux surgery. World J Surg 16:335–336PubMedCrossRef

74.

Pessaux P, Arnaud JP, Delattre JF, Meyer C, Baulieux J, Mosnier H (2005) Laparoscopic antireflux surgery: five-year results and beyond in 1340 patients. Arch Surg 140:946–951PubMedCrossRef

75.

Bonatti H, Bammer T, Achem SR, Lukens F, Devault KR, Klaus A, Hinder RA (2007) Use of acid suppressive medications after laparoscopic antireflux surgery: prevalence and clinical indications. Dig Dis Sci 52:267–272PubMedCrossRef

76.

Booth MI, Jones L, Stratford J, Dehn TC (2002) Results of laparoscopic Nissen fundoplication at 2–8 years after surgery. Br J Surg 89:476–481PubMedCrossRef

77.

Lundell L, Miettinen P, Myrvold HE, Pedersen SA, Thor K, Lamm M, Blomqvist A, Hatlebakk JG, Janatuinen E, Levander K, Nystrom P, Wiklund I (2000) Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial. The nordic gord study group. Eur J Gastroenterol Hepatol 12:879–887PubMedCrossRef

78.

Spechler SJ (1992) Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The department of Veterans Affairs gastroesophageal reflux disease study group. N Engl J Med 326:786–792PubMed

79.

Cookson R, Flood C, Koo B, Mahon D, Rhodes M (2005) Short-term cost effectiveness and long-term cost analysis comparing laparoscopic Nissen fundoplication with proton-pump inhibitor maintenance for gastro-oesophageal reflux disease. Br J Surg 92:700–706PubMedCrossRef

80.

Bloomston M, Zervos E, Gonzalez R, Albrink M, Rosemurgy A (1998) Quality of life and antireflux medication use following laparoscopic Nissen fundoplication. Am Surg 64:509–513PubMed

Title: The use of medication after laparoscopic antireflux surgery
Authors: Ruxandra Ciovica
Otto Riedl
Christoph Neumayer
Wolfgang Lechner
Gerhard P. Schwab
Michael Gadenstätter
Publication date: 01-09-2009
Publisher: Springer-Verlag
Published in: Surgical Endoscopy / Issue 9/2009
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI: https://doi.org/10.1007/s00464-008-0271-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The use of medication after laparoscopic antireflux surgery

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 9/2009

Pressure-dependent hydrometra dimensions in hysteroscopy

The role of diagnostic laparoscopy for chronic abdominal conditions: an evidence-based review

Realistic and affordable lo-fidelity model for learning bronchoscopic transbronchial needle aspiration

Development of an articulating ultrasonically activated device for laparoscopic surgery

Transcervical incision of septa: 447 cases

The point of conversion in laparoscopic colonic surgery affects the oncologic outcome in an experimental rat model